Medico Remedies Limited (BOM:540937)

Market Cap	3.28B -15.2%
Revenue (ttm)	1.91B +26.4%
Net Income	115.99M +31.0%
EPS	1.40 +32.1%
Shares Out	82.98M
PE Ratio	28.25
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	34,591
Average Volume	14,051
Open	39.31
Previous Close	38.63
Day's Range	38.63 - 40.37
52-Week Range	31.00 - 62.00
Beta	0.40
RSI	47.53
Earnings Date	May 30, 2026

About Medico Remedies

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 213
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540937

Financial Performance

In fiscal year 2025, Medico Remedies's revenue was 1.51 billion, an increase of 4.15% compared to the previous year's 1.45 billion. Earnings were 100.93 million, an increase of 21.74%.